Idéal Investisseur Connexion Connexion
Français English
CAC 40 : Market open
7 970,89 pts
-1.36%


Last updated : 20/11/2026 - 12h41
🏠 Home   ➤    Stock news

Inventiva shares fall 14.5% in a week, erasing their October rebound

The Burgundy-based biotech specialising in fibrotic and metabolic diseases declines mid-session, in a Paris market that is also sharply lower. The stock extends the decline begun earlier this week and ranks near the bottom of the index.


Inventiva shares fall 14.5% in a week, erasing their October rebound

A stock that has slipped below its short-term averages after its October rebound

The Inventiva stock is down 3% at €3.07, after a 14.4% fall over the week that wipes out most of the rebound begun at the end of October. The stock now sits 7% below its MM20 and just 1.6% below its MM50, while the MM200 remains far away, more than 23% above the price.

The decline comes as the SBF 120 loses 1.22% and the stock ranks among the largest decliners in the index. The RSI at 46 remains neutral, indicating that this week's drop has not pushed the stock into oversold territory. A month earlier, the stock had gained 13.5%, and it retains those gains despite the recent slide.

Cash covered until the second quarter of 2027 and revenue expected on Monday

When it published its H1 2026 results on 29 July 2026, the company had indicated that its cash did not cover operating requirements for the next twelve months, with a horizon limited to the end of the second quarter of 2027 without additional financing. It had also recalled the €75 million financing transaction and the €103 million share offering announced on 2 June 2026.

The group recorded no revenue in the first half of 2026, compared with €4.5 million a year earlier. Its third-quarter revenue is expected on 23 November, the next date on the calendar.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Pharmacie et biotechnologies › Biotechnologies


Context

Period
  • Period: S1 2026
Key reported figures
  • Revenue: 0 millions d'euros
  • Quarterly revenue: 0 millions d'euros
  • Revenue growth: -100 %
  • Net income: -69,5 millions d'euros
  • Free cash flow: -48,7 millions d'euros
Risks mentioned
  • La trésorerie actuelle ne couvre pas les besoins opérationnels des 12 prochains mois.
  • Horizon de trésorerie limité à la fin du deuxième trimestre 2027 sans financements additionnels.
  • Aucun chiffre d'affaires enregistré au premier semestre 2026, contre 4,5 M€ un an plus tôt.
Opportunities identified
  • Offre Equity de 103 M€ et Opération de Financement de 75 M€ annoncées le 2 juin 2026.
  • Tranche C de l'Opération de Financement pouvant apporter jusqu'à 20,0 M€.
  • Exercice des warrants Tranche 3 pouvant générer jusqu'à 116,0 M€.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours